- Home
- OMGA vs CLNN Comparison
OMGA vs CLNN Comparison
Compare OMGA & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMGA
- CLNN
- Stock Information
- Founded
- OMGA 2017
- CLNN 2012
- Country
- OMGA United States
- CLNN United States
- Employees
- OMGA N/A
- CLNN N/A
- Industry
- OMGA Biotechnology: Pharmaceutical Preparations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- OMGA Health Care
- CLNN Health Care
- Exchange
- OMGA Nasdaq
- CLNN Nasdaq
- Market Cap
- OMGA 27.1M
- CLNN 43.0M
- IPO Year
- OMGA 2021
- CLNN N/A
- Fundamental
- Price
- OMGA $0.14
- CLNN $4.69
- Analyst Decision
- OMGA Strong Buy
- CLNN Strong Buy
- Analyst Count
- OMGA 5
- CLNN 4
- Target Price
- OMGA $9.20
- CLNN $55.25
- AVG Volume (30 Days)
- OMGA 1.2M
- CLNN 66.7K
- Earning Date
- OMGA 03-27-2025
- CLNN 03-12-2025
- Dividend Yield
- OMGA N/A
- CLNN N/A
- EPS Growth
- OMGA N/A
- CLNN N/A
- EPS
- OMGA N/A
- CLNN N/A
- Revenue
- OMGA $8,095,000.00
- CLNN $421,000.00
- Revenue This Year
- OMGA $181.38
- CLNN N/A
- Revenue Next Year
- OMGA N/A
- CLNN N/A
- P/E Ratio
- OMGA N/A
- CLNN N/A
- Revenue Growth
- OMGA 185.04
- CLNN N/A
- 52 Week Low
- OMGA $0.14
- CLNN $3.82
- 52 Week High
- OMGA $4.46
- CLNN $10.60
- Technical
- Relative Strength Index (RSI)
- OMGA 19.88
- CLNN 43.93
- Support Level
- OMGA $0.44
- CLNN $4.41
- Resistance Level
- OMGA $0.54
- CLNN $4.85
- Average True Range (ATR)
- OMGA 0.09
- CLNN 0.28
- MACD
- OMGA -0.02
- CLNN -0.05
- Stochastic Oscillator
- OMGA 2.09
- CLNN 33.23
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).